13th Jul 2016 07:00
LONDON (Alliance News) - AIM and Nasdaq listed GW Pharmaceuticals PLC on Wednesday said it had priced its offering of 2.8 million American Depositary Shares at USD90.00, raising around USD252.0 million.
The ADSs represent 33.6 million ordinary shares in the company.
Morgan Stanley, Bank of America Merrill Lynch and Goldman Sachs & Co are joint book-running managers for the offering, expected to close next Monday.
GW Pharmaceuticals has granted the underwriters a 30-day option to buy up to an additional 420,000 ADS' at the public offering price.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2016 Alliance News Limited. All Rights Reserved.